Hickey Benjamin
- SEC CIK
- 0001753055
No open-market purchases or sales filed in the past year.
Current role at each company
- BMY Bristol Myers Squibb CoPresident, RayzeBio Org.as of Mar 12, 2026
- MURA Mural Oncology plcDirectoras of Dec 5, 2025
- MRTX Mirati Therapeutics, Inc.EVP, Chief Commercial Officeras of Jan 23, 2024
- SURF Surface Oncology, Inc.Directoras of Jun 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hickey Benjamin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMY Bristol Myers Squibb Co
President, RayzeBio Org.1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 (view filing) | May 9 | 4 days | Hickey BenjaminPresident, RayzeBio Org. | SSaleCommon Stock, $0.10 par value | −97.39 | $38.01 | −$3.70K | −100.0%0 after |
MRTX Mirati Therapeutics, Inc.
EVP, Chief Commercial Officer8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.60K | $59.02 | −$94.3K | −1.3%117.0K after | 2 lots |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.09K | $58.92 | −$123.1K | −1.7%118.6K after | |
| Dec 14, 2023 (view filing) | Dec 13 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.22K | $56.67 | −$125.8K | −2.1%103.7K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.57K | $42.38 | −$66.4K | −3.2%47.2K after | 2 lots |
| Jan 10, 2023 (view filing) | Jan 9 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.09K | $45.37 | −$94.7K | −4.1%48.8K after | |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −3.25K | $40.41 | −$131.3K | −6.0%50.9K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −627 | $120.48 | −$75.5K | −1.8%35.0K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.96K | $135.94 | −$267.0K | −7.3%24.8K after |